Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis

BACKGROUND: Systemic juvenile idiopathic arthritis (SoJIA) is the most striking form of juvenile idiopathic arthritis. The aim of our study was to evaluate the clinical responses and outcomes of children with SoJIA to IL-6 blockade using two different tocilizumab (TCZ) treatment protocols designed f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostik, Mikhail M, Dubko, Margarita F, Masalova, Vera V, Snegireva, Ludmila S, Kornishina, Tatyana L, Chikova, Irina A, Isupova, Eugenia A, Kuchinskaya, Ekaterina M, Glebova, Natalia I, Buchinskaya, Natalia V, Kalashnikova, Olga V, Chasnyk, Vyacheslav G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328569/
https://www.ncbi.nlm.nih.gov/pubmed/25685108
http://dx.doi.org/10.1186/1546-0096-13-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328569/
https://www.ncbi.nlm.nih.gov/pubmed/25685108
http://dx.doi.org/10.1186/1546-0096-13-4

Ejemplares similares